ATE356202T1 - Attenuierte stabile tollwutvirusmutante und lebende impfstoffe - Google Patents

Attenuierte stabile tollwutvirusmutante und lebende impfstoffe

Info

Publication number
ATE356202T1
ATE356202T1 AT99973064T AT99973064T ATE356202T1 AT E356202 T1 ATE356202 T1 AT E356202T1 AT 99973064 T AT99973064 T AT 99973064T AT 99973064 T AT99973064 T AT 99973064T AT E356202 T1 ATE356202 T1 AT E356202T1
Authority
AT
Austria
Prior art keywords
attenuated
stable
rabies virus
live vaccines
virus mutant
Prior art date
Application number
AT99973064T
Other languages
English (en)
Inventor
Teshome Mebatsion
Karl Klaus Conzelmann
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE356202T1 publication Critical patent/ATE356202T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99973064T 1998-11-27 1999-11-19 Attenuierte stabile tollwutvirusmutante und lebende impfstoffe ATE356202T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98204001 1998-11-27

Publications (1)

Publication Number Publication Date
ATE356202T1 true ATE356202T1 (de) 2007-03-15

Family

ID=8234392

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99973064T ATE356202T1 (de) 1998-11-27 1999-11-19 Attenuierte stabile tollwutvirusmutante und lebende impfstoffe

Country Status (16)

Country Link
US (1) US6719981B1 (de)
EP (1) EP1131414B1 (de)
AR (1) AR021406A1 (de)
AT (1) ATE356202T1 (de)
AU (1) AU1386100A (de)
BR (1) BR9915703B1 (de)
CA (1) CA2352231C (de)
CY (1) CY1106570T1 (de)
DE (1) DE69935445T2 (de)
DK (1) DK1131414T3 (de)
ES (1) ES2283150T3 (de)
ID (1) ID28968A (de)
IL (2) IL143149A0 (de)
PT (1) PT1131414E (de)
TR (1) TR200101445T2 (de)
WO (1) WO2000032755A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE316572T1 (de) 2001-04-23 2006-02-15 Akzo Nobel Nv Attenuierte rekombinante stabile tollwutvirusmutanten und lebendimpfstoffe
EP1434862A4 (de) 2001-07-20 2005-04-06 Univ Georgia Res Found Attenuiertes tollwutvirus mit einer nukleoproteinmutation an der phosphorylierungsstelle zur impfung gegen tollwut und gentherapie im zns
CA2943039C (en) 2005-10-14 2018-11-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus compositions and methods
US7785874B2 (en) * 2007-01-11 2010-08-31 The Salk Institute For Biological Studies Compositions and methods for monosynaptic transport
TW200907058A (en) * 2007-05-30 2009-02-16 Wyeth Corp Raccoon poxvirus expressing rabies glycoproteins
WO2012106490A1 (en) 2011-02-03 2012-08-09 The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and filoviruses
CN103865889B (zh) * 2014-04-03 2015-02-25 深圳市卫光生物制品股份有限公司 狂犬病病毒ctn鸡胚细胞适应株
EP3439695B1 (de) 2016-04-04 2022-05-04 The U.S.A. as represented by the Secretary, Department of Health and Human Services Multivalente impfstoffe gegen tollwut- und coronaviren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent
FR2693655B1 (fr) * 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
SE0002498D0 (sv) 2000-07-03 2000-07-03 Stefan Schwartz Papillomavirus vaccine
WO2003050398A1 (en) 2001-12-10 2003-06-19 Donaldson Company, Inc. Exhaust treatment control system for an internal combustion engine
DE102004009653A1 (de) 2004-02-27 2005-09-22 Cycos Ag Kommunikationsserver und Verfahren zum Aufbau und Betrieb einer Konferenz-Kommunikationsverbindung

Also Published As

Publication number Publication date
US6719981B1 (en) 2004-04-13
IL143149A (en) 2007-12-03
IL143149A0 (en) 2002-04-21
CY1106570T1 (el) 2012-01-25
PT1131414E (pt) 2007-04-30
ID28968A (id) 2001-07-19
DK1131414T3 (da) 2007-06-18
AR021406A1 (es) 2002-07-17
BR9915703A (pt) 2001-08-14
EP1131414B1 (de) 2007-03-07
AU1386100A (en) 2000-06-19
EP1131414A1 (de) 2001-09-12
BR9915703B1 (pt) 2012-09-04
CA2352231A1 (en) 2000-06-08
DE69935445D1 (de) 2007-04-19
CA2352231C (en) 2010-06-01
TR200101445T2 (tr) 2001-10-22
WO2000032755A1 (en) 2000-06-08
DE69935445T2 (de) 2007-11-29
ES2283150T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
DE60135059D1 (de) Positionsabhängiges Chatsystem und Verfahren
NL300311I1 (nl) Adjuvanssytemen en vaccins
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
DE60126977D1 (de) Chirurgisches system mit griff und kanule
ATE245969T1 (de) Stabile glasartige pulverformulierungen
AU7490601A (en) Methods and compositions for treating hepatitis c virus
EP1083926A4 (de) Impfstoff
NO20030239L (no) Modifisert virus
DK2116257T3 (da) Parenterale vaccineformuleringer og anvendelser deraf
AU4529401A (en) Aids ancestral viruses and vaccines
DK1131414T3 (da) Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf
NO20005599D0 (no) Vaksine
DE60208854D1 (de) Attenuierte rekombinante stabile Tollwutvirusmutanten und Lebendimpfstoffe
MXPA03002875A (es) Composicion de vacuna y metodo de estabilizacion.
ATE345815T1 (de) Kombinierte impfstoffe gegen hepatitis a und hepatitis b
ID28775A (id) Disinfektan yang bekerja lama dan metode penyiapannya
IS6184A (is) Bóluefni gegn ISA veiru
DE69835346D1 (de) Vakzine gegen infektiöse bursitis
IS5778A (is) Stökkbrigði af mennskri lifrarbólgu B veiru og notkun hennar
ATE431415T1 (de) Hiv impfstoff
ID28142A (id) Jenis virus penyebab hepatitis b vaksin dan penggunaannya
FI20001912A0 (fi) Menetelmä sekä vastaanotin
PT841943E (pt) Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas
IL149173A0 (en) Attenuated recombinant rabies virus mutants and live vaccines thereof
SE0000932D0 (sv) System och förfarande

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1131414

Country of ref document: EP